The antibiotic, marketed as Xacduro, is indicated for hospital-acquired bacterial pneumonia (HABP) and ventilator-associated bacterial pneumonia (VABP) caused by susceptible strains of bacteria called Acinetobacter baumannii.

New data from Digestive Disease Week furthers evidence that biologics can be effective

Data presented at Digestive Disease Week show that patients with IBD had less intense post-vaccination symptoms after a fourth dose.

Writing op-eds, speaking at community centers, and participating in local 5K events are just a few ways to generate buzz about your pharmacy–for free.

This treatment is the first and only long-acting buprenorphine injectable with weekly and monthly doses.

The newly FDA-approved prescription product delivers nalmefene to the nasal cavity to reverse the effects of opioid overdose.

Active tobacco use and BMI were inversely related to the risk of developing IPD.

Exhaled carbon monoxide in vape users significantly decreased between their first and third clinical visits.

According to commentaries published in the Annals of Internal Medicine, doctors remain split on the question.

Some patients with PAH need to travel long distances, which may impact their access to quality care providers.

A higher dose of the carbonic anhydrase inhibitor does not seem to provide any additional improvements.

The approval of Rinvoq (upadacitinib) was based on the results of three clinical trials: two induction therapy studies and one maintenance study.

Your weekly roundup of the latest news from Drug Topics®.

Relocation led to a reduction in asthma exacerbations, exceeding the effect of inhaled corticosteroids, and was similar to biologic agents.

Researchers found a significant decrease in mortality or discharge to hospice with the hydrocortisone-fludrocortisone combination versus hydrocortisone alone in septic shock cases.

Seasonal influenza kills hundreds of thousands of people every year due to a constantly changing virus and highly inefficient vaccine production. A universal flu vaccine could deal with the first problem, and mRNA technology with the second.

Health plans must continue providing free screenings pending court’s further consideration of case.

Data suggest a substantial reliance on established therapies for polycythemia vera, despite access to all available treatment options.

How much progress have we made in developing therapies to treat this common childhood respiratory disorder?

Following some improvement, excess death rate returned to 1999 levels for Black men and 2005 levels for Black women.

The REFLECT Scoliosis Correction System from Globus Medical is intended to correct progressive scoliosis in pediatric patients while simultaneously maintaining stability and motion as well as allowing for future modulated growth.

Authors offered specific recommendations for improving publishing and adoption of algorithmic processes focused on type 2 diabetes (T2D) going forward.

The atrial fibrillation drug, asundexian, may provide protection from thrombotic events without a corresponding increase in bleeding risk.

The atrial fibrillation drug, asundexian, may provide protection from thrombotic events without a corresponding increase in bleeding risk.

The National Community Pharmacists Association now has plenty of allies in its fight with the pharmacy benefit managers.